drugset / Trial / NCT00910273
Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
Study to assess whether etanercept therapy is able to increase flow-mediated vasodilatation in AS, and whether etanercept can modify the intima-media thickness (IMT) in these patients
Timeline
- Start
- 2009-07
- Primary completion
- 2011-10
- Completion
- 2011-10
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Etanercept vs Placebo; p = 0.608; Mean Difference (Final Values) 1.72 (95% CI -5.14 to 8.58); Mixed Models Analysis NCT00910273 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | — |